{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:12:54Z","timestamp":1792037574844,"version":"4.4.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007277","name":"Icahn School of Medicine at Mount Sinai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007277","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008072","name":"Gladstone Institutes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009724","name":"Roddenberry Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009724","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013119","name":"PharmaMar","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013119","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2020-117145RB-I00"],"award-info":[{"award-number":["PID2020-117145RB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2023-147498OB-I00"],"award-info":[{"award-number":["PID2023-147498OB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI153356"],"award-info":[{"award-number":["R01AI153356"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL169500"],"award-info":[{"award-number":["R01HL169500"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI163011"],"award-info":[{"award-number":["R01AI163011"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35GM137905"],"award-info":[{"award-number":["R35GM137905"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI137200"],"award-info":[{"award-number":["R01AI137200"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["G20AI174733"],"award-info":[{"award-number":["G20AI174733"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["PRE2021-099271"],"award-info":[{"award-number":["PRE2021-099271"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Aspects of Medicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.mam.2025.101412","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T14:45:24Z","timestamp":1762785924000},"page":"101412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Pharmacological reprogramming of plitidepsin as a SARS-CoV-2 inhibitor"],"prefix":"10.1016","volume":"106","author":[{"given":"Jose","family":"Jimeno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Felipe","family":"Varona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Lopez-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Izquierdo-Useros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Molina Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Guisado-Vasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Sachse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Risco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Losada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Fudio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Luepke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Nieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Aviles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Cuevas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Bouhaddou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Sola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nevan J.","family":"Krogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Enjuanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M.","family":"Fernandez-Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"Garc\u00cda-Sastre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0889-0506","authenticated-orcid":false,"given":"Kris","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mam.2025.101412_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijid.2023.07.011","article-title":"Outcomes and clinical characteristics of the compassionate use of plitidepsin for immunocompromised adult patients with COVID-19","volume":"135","author":"Aguareles","year":"2023","journal-title":"Int. J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.mam.2025.101412_bib3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/23744235.2024.2351043","article-title":"Outcomes and clinical characteristics of the compassionate use of plitidepsin in COVID-19 patients with solid tumours, haematological malignancies or anti-CD20 antibody treatment","volume":"56","author":"Aguareles","year":"2024","journal-title":"Infect Dis (Lond)."},{"issue":"11","key":"10.1016\/j.mam.2025.101412_bib4","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/annonc\/mdg443","article-title":"Progress in the development and acquisition of anticancer agents from marine sources","volume":"14","author":"Amador","year":"2003","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.mam.2025.101412_bib5","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00524-13","article-title":"Severe acute respiratory syndrome coronavirus nonstructural proteins 3, 4, and 6 induce double-membrane vesicles","volume":"4","author":"Angelini","year":"2013","journal-title":"mBio"},{"issue":"10","key":"10.1016\/j.mam.2025.101412_bib6","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41564-021-00958-0","article-title":"Cellular host factors for SARS-CoV-2 infection","volume":"6","author":"Baggen","year":"2021","journal-title":"Nat. Microbiol."},{"issue":"25","key":"10.1016\/j.mam.2025.101412_bib7","doi-asserted-by":"crossref","first-page":"6506","DOI":"10.1073\/pnas.1711842115","article-title":"The biomass distribution on Earth","volume":"115","author":"Bar-On","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mam.2025.101412_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ddmod.2019.08.008","article-title":"Tunicates: a model organism to investigate the effects of associated-microbiota on the production of pharmaceuticals","volume":"28","author":"Bauermeister","year":"2018","journal-title":"Drug Discov. Today Dis. Model."},{"issue":"11","key":"10.1016\/j.mam.2025.101412_bib9","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.cmi.2020.07.024","article-title":"Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain","volume":"26","author":"Berenguer","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"issue":"6","key":"10.1016\/j.mam.2025.101412_bib10","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.pharma.2023.06.001","article-title":"Blue marine therapy: sea as a trove of natural anticancer drugs","volume":"81","author":"Bettio","year":"2023","journal-title":"Ann. Pharm. Fr."},{"issue":"10","key":"10.1016\/j.mam.2025.101412_bib11","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/annonc\/mdi311","article-title":"VEGF inhibition and cytotoxic effect of aplidin in leukemia cell lines and cells from acute myeloid leukemia","volume":"16","author":"Biscardi","year":"2005","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.mam.2025.101412_bib12","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1002\/jmv.26720","article-title":"Cellular mechanisms underlying neurological\/neuropsychiatric manifestations of COVID-19","volume":"93","author":"Bodnar","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.mam.2025.101412_bib14","series-title":"Developments in Palaeontology and Stratigraphy","first-page":"371","article-title":"Species diversity: land and sea","year":"1995"},{"issue":"1","key":"10.1016\/j.mam.2025.101412_bib15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/sj.leu.2402788","article-title":"Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia cells MOLT-4","volume":"17","author":"Broggini","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.mam.2025.101412_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2023.104254","article-title":"Emerging pharmaceutical therapies of Ascidian-derived natural products and derivatives","volume":"102","author":"Cooreman","year":"2023","journal-title":"Environ. Toxicol. Pharmacol."},{"issue":"6","key":"10.1016\/j.mam.2025.101412_bib17","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1056\/NEJMsb2104756","article-title":"SARS-CoV-2 variants in patients with immunosuppression","volume":"385","author":"Corey","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.mam.2025.101412_bib18","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.4161\/auto.29309","article-title":"Coronavirus NSP6 restricts autophagosome expansion","volume":"10","author":"Cottam","year":"2014","journal-title":"Autophagy"},{"issue":"5","key":"10.1016\/j.mam.2025.101412_bib19","first-page":"1796","article-title":"Biochemical and cellular effects of didemnins A and B","volume":"44","author":"Crampton","year":"1984","journal-title":"Cancer Res."},{"issue":"22","key":"10.1016\/j.mam.2025.101412_bib20","doi-asserted-by":"crossref","first-page":"15411","DOI":"10.1016\/S0021-9258(17)40692-2","article-title":"GTP-dependent binding of the antiproliferative agent didemnin to elongation factor 1 alpha","volume":"269","author":"Crews","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.mam.2025.101412_bib21","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.immuni.2022.09.006","article-title":"SARS-CoV-2 in immunocompromised individuals","volume":"55","author":"DeWolf","year":"2022","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.mam.2025.101412_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/md17120670","article-title":"Origins and bioactivities of natural compounds derived from marine ascidians and their symbionts","volume":"17","author":"Dou","year":"2019","journal-title":"Mar. Drugs"},{"issue":"9","key":"10.1016\/j.mam.2025.101412_bib23","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1038\/sj.bjc.6600265","article-title":"Cell cycle phase perturbations and apoptosis in tumour cells induced by aplidine","volume":"86","author":"Erba","year":"2002","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.mam.2025.101412_bib24","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1182\/blood.2021012250","article-title":"Vasculopathy in COVID-19","volume":"140","author":"Flaumenhaft","year":"2022","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.mam.2025.101412_bib25","first-page":"12","article-title":"Tunicates as sources of high-quality nutrients and bioactive compounds for food\/feed and pharmaceutical applications: a review","author":"Gao","year":"2023","journal-title":"Foods"},{"issue":"7816","key":"10.1016\/j.mam.2025.101412_bib26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.mam.2025.101412_bib27","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2019.03.040","article-title":"Marine DNA viral macro- and microdiversity from Pole to Pole","volume":"177","author":"Gregory","year":"2019","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.mam.2025.101412_bib28","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.annonc.2021.07.003","article-title":"Plitidepsin for the management of a cancer patient infected with SARS-CoV-2 while receiving chemotherapy","volume":"32","author":"Guisado-Vasco","year":"2021","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.mam.2025.101412_bib29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13045-021-01220-0","article-title":"Plitidepsin as a successful rescue treatment for prolonged viral SARS-CoV-2 replication in a patient with previous anti-CD20 monoclonal antibody-mediated B cell depletion and chronic lymphocytic leukemia","volume":"15","author":"Guisado-Vasco","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"24","key":"10.1016\/j.mam.2025.101412_bib30","doi-asserted-by":"crossref","first-page":"6929","DOI":"10.1016\/j.cell.2024.09.027","article-title":"Using artificial intelligence to document the hidden RNA virosphere","volume":"187","author":"Hou","year":"2024","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.mam.2025.101412_bib31","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1038\/sj.leu.2404911","article-title":"Aplidin synergizes with cytosine arabinoside: functional relevance of mitochondria in Aplidin-induced cytotoxicity","volume":"21","author":"Humeniuk","year":"2007","journal-title":"Leukemia"},{"issue":"Suppl. 1","key":"10.1016\/j.mam.2025.101412_bib32","first-page":"S15","article-title":"A clinical armamentarium of marine-derived anti-cancer compounds","volume":"13","author":"Jimeno","year":"2002","journal-title":"Anti Cancer Drugs"},{"key":"10.1016\/j.mam.2025.101412_bib34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1479-5876-4-3","article-title":"Adding pharmacogenomics to the development of new marine-derived anticancer agents","volume":"4","author":"Jimeno","year":"2006","journal-title":"J. Transl. Med."},{"issue":"15","key":"10.1016\/j.mam.2025.101412_bib35","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1093\/cvr\/cvac097","article-title":"Preferential uptake of SARS-CoV-2 by pericytes potentiates vascular damage and permeability in an organoid model of the microvasculature","volume":"118","author":"Khan","year":"2022","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.mam.2025.101412_bib36","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00000421-200006000-00013","article-title":"Phase II trail of didemnin B in previously treated non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group (ECOG) Study","volume":"23","author":"Kucuk","year":"2000","journal-title":"Am. J. Clin. Oncol."},{"issue":"10241","key":"10.1016\/j.mam.2025.101412_bib37","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(20)31187-9","article-title":"Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study","volume":"395","author":"Kuderer","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.mam.2025.101412_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/v15040856","article-title":"Understanding mutations in human SARS-CoV-2 spike glycoprotein: a systematic review & meta-analysis","volume":"15","author":"Kumar","year":"2023","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.mam.2025.101412_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.31579\/2690-4861\/352","article-title":"SARS-CoV-2-related persistent pulmonary affection case in a 55-year-old gastric MALT lymphoma patient on rituximab","volume":"15","author":"Landete","year":"2023","journal-title":"International Journal of Clinical Case Reports and Reviews"},{"issue":"4","key":"10.1016\/j.mam.2025.101412_bib41","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/cid\/ciae227","article-title":"A phase III randomized controlled trial of plitidepsin, a marine-derived compound, in hospitalized adults with moderate COVID-19","volume":"79","author":"Landete","year":"2024","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.mam.2025.101412_bib42","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1574-6976.2008.00132.x","article-title":"RNA viruses in the sea","volume":"33","author":"Lang","year":"2009","journal-title":"FEMS Microbiol. Rev."},{"issue":"1","key":"10.1016\/j.mam.2025.101412_bib43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12931-021-01798-6","article-title":"Pulmonary fibrosis and its related factors in discharged patients with new corona virus pneumonia: a cohort study","volume":"22","author":"Li","year":"2021","journal-title":"Respir. Res."},{"key":"10.1016\/j.mam.2025.101412_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-kappaB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.mam.2025.101412_bib45","article-title":"More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis","author":"Lopez-Leon","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.mam.2025.101412_bib46","series-title":"International Conference on Antiviral Research","article-title":"Unveiiling antiviral mechanisms of plitidepsin by in silico transcriptomic analysis presented at","author":"Lopez-Martin","year":"2023"},{"key":"10.1016\/j.mam.2025.101412_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/srep35100","article-title":"Translation elongation factor eEF1A2 is a novel anticancer target for the marine natural product plitidepsin","volume":"6","author":"Losada","year":"2016","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.mam.2025.101412_bib48","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/s41416-018-0336-y","article-title":"Binding of eEF1A2 to the RNA-dependent protein kinase PKR modulates its activity and promotes tumour cell survival","volume":"119","author":"Losada","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.mam.2025.101412_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113744","article-title":"Generation of endoplasmic reticulum stress and inhibition of autophagy by plitidepsin induces proteotoxic apoptosis in cancer cells","volume":"172","author":"Losada","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.mam.2025.101412_bib50","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.annepidem.2021.02.012","article-title":"COVID-19 fatality rates in hospitalized patients: systematic review and meta-analysis","volume":"57","author":"Macedo","year":"2021","journal-title":"Ann. Epidemiol."},{"issue":"9","key":"10.1016\/j.mam.2025.101412_bib51","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/annonc\/mdl165","article-title":"Phase I study of Aplidine in a dailyx5 one-hour infusion every 3 weeks in patients with solid tumors refractory to standard therapy. A National Cancer Institute of Canada Clinical Trials Group study: NCIC ctg IND 115","volume":"17","author":"Maroun","year":"2006","journal-title":"Ann. Oncol."},{"issue":"12","key":"10.1016\/j.mam.2025.101412_bib52","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1158\/1078-0432.CCR-10-0469","article-title":"Phase II clinical and pharmacokinetic study of plitidepsin 3-hour infusion every two weeks alone or with dexamethasone in relapsed and refractory multiple myeloma","volume":"16","author":"Mateos","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"28","key":"10.1016\/j.mam.2025.101412_bib53","doi-asserted-by":"crossref","first-page":"21209","DOI":"10.1074\/jbc.R110.113795","article-title":"eEF1A: thinking outside the ribosome","volume":"285","author":"Mateyak","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.mam.2025.101412_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27041449","article-title":"Anticancer activities of marine-derived phenolic compounds and their derivatives","volume":"27","author":"Matulja","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.mam.2025.101412_bib55","series-title":"Stepwise Evolution and Exceptional Conservation of ORF1a\/b Overlap in Coronaviruses","author":"Mei","year":"2021"},{"key":"10.1016\/j.mam.2025.101412_bib56","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1146\/annurev.bi.54.070185.005333","article-title":"Eukaryotic protein synthesis","volume":"54","author":"Moldave","year":"1985","journal-title":"Annu. Rev. Biochem."},{"issue":"4","key":"10.1016\/j.mam.2025.101412_bib57","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1158\/1535-7163.MCT-06-0729","article-title":"Levels of p27(kip1) determine Aplidin sensitivity","volume":"6","author":"Moneo","year":"2007","journal-title":"Mol. Cancer Therapeut."},{"issue":"5","key":"10.1016\/j.mam.2025.101412_bib58","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1007\/s10637-011-9740-3","article-title":"The cytotoxic activity of Aplidin in chronic lymphocytic leukemia (CLL) is mediated by a direct effect on leukemic cells and an indirect effect on monocyte-derived cells","volume":"30","author":"Morande","year":"2012","journal-title":"Invest. N. Drugs"},{"issue":"1","key":"10.1016\/j.mam.2025.101412_bib59","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00280-008-0841-4","article-title":"Population pharmacokinetics meta-analysis of plitidepsin (Aplidin) in cancer subjects","volume":"64","author":"Nalda-Molina","year":"2009","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"8","key":"10.1016\/j.mam.2025.101412_bib60","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1021\/np040031y","article-title":"Marine natural products and related compounds in clinical and advanced preclinical trials","volume":"67","author":"Newman","year":"2004","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.mam.2025.101412_bib62","series-title":"International Conference on Antiviral Research","article-title":"Pltidepsin is a host directed antiviral that transiently inhibits protein translation of distant viruses while shaping a protective proteostatic cellular response presented at","author":"Perez-Zsolt","year":"2023"},{"issue":"6","key":"10.1016\/j.mam.2025.101412_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/md19060308","article-title":"Marine natural products from tunicates and their associated microbes","volume":"19","author":"Ramesh","year":"2021","journal-title":"Mar. Drugs"},{"issue":"3","key":"10.1016\/j.mam.2025.101412_bib64","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3324\/haematol.2012.069757","article-title":"Multicenter phase II study of plitidepsin in patients with relapsed\/refractory non-Hodgkin's lymphoma","volume":"98","author":"Ribrag","year":"2013","journal-title":"Haematologica"},{"issue":"4497","key":"10.1016\/j.mam.2025.101412_bib65","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1126\/science.7233187","article-title":"Didemnins: antiviral and antitumor depsipeptides from a caribbean tunicate","volume":"212","author":"Rinehart","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.mam.2025.101412_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.646676","article-title":"Identification of plitidepsin as potent inhibitor of SARS-CoV-2-induced cytopathic effect after a drug repurposing screen","volume":"12","author":"Rodon","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.mam.2025.101412_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105270","article-title":"Unraveling the antiviral activity of plitidepsin against SARS-CoV-2 by subcellular and morphological analysis","volume":"200","author":"Sachse","year":"2022","journal-title":"Antivir. Res."},{"issue":"4","key":"10.1016\/j.mam.2025.101412_bib68","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1470-2045(00)00292-8","article-title":"Marine organisms as a source of new anticancer agents","volume":"2","author":"Schwartsmann","year":"2001","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.mam.2025.101412_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020657","article-title":"Global diversity of ascidiacea","volume":"6","author":"Shenkar","year":"2011","journal-title":"PLoS One"},{"issue":"28","key":"10.1016\/j.mam.2025.101412_bib70","doi-asserted-by":"crossref","first-page":"9177","DOI":"10.1021\/bi00028a030","article-title":"Mechanism of protein synthesis inhibition by didemnin B in vitro","volume":"34","author":"SirDeshpande","year":"1995","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.mam.2025.101412_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000756","article-title":"Exacerbated innate host response to SARS-CoV in aged non-human primates","volume":"6","author":"Smits","year":"2010","journal-title":"PLoS Pathog."},{"issue":"9","key":"10.1016\/j.mam.2025.101412_bib72","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1007\/s00277-019-03739-2","article-title":"Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed\/refractory multiple myeloma","volume":"98","author":"Spicka","year":"2019","journal-title":"Ann. Hematol."},{"issue":"10","key":"10.1016\/j.mam.2025.101412_bib73","doi-asserted-by":"crossref","DOI":"10.3390\/md19100530","article-title":"Marine bacterial secondary metabolites: a treasure house for structurally unique and effective antimicrobial compounds","volume":"19","author":"Srinivasan","year":"2021","journal-title":"Mar. Drugs"},{"issue":"2","key":"10.1016\/j.mam.2025.101412_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/md21020056","article-title":"A survey of didemnin depsipeptide production in Tistrella","volume":"21","author":"Stankey","year":"2023","journal-title":"Mar. Drugs"},{"issue":"1","key":"10.1016\/j.mam.2025.101412_bib75","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00280-005-0014-7","article-title":"Aplidin reduces growth of anaplastic thyroid cancer xenografts and the expression of several angiogenic genes","volume":"57","author":"Straight","year":"2006","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"2","key":"10.1016\/j.mam.2025.101412_bib76","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF00166813","article-title":"The significance of viruses to mortality in aquatic microbial communities","volume":"28","author":"Suttle","year":"1994","journal-title":"Microb. Ecol."},{"issue":"11","key":"10.1016\/j.mam.2025.101412_bib77","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1021\/np200543z","article-title":"Bacterial production of the tunicate-derived antitumor cyclic depsipeptide didemnin B","volume":"74","author":"Tsukimoto","year":"2011","journal-title":"J. Nat. Prod."},{"issue":"4","key":"10.1016\/j.mam.2025.101412_bib78","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202101200","article-title":"Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19","volume":"5","author":"Varona","year":"2022","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.mam.2025.101412_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1097809","article-title":"Plitidepsin in adult patients with COVID-19 requiring hospital admission: a long-term follow-up analysis","volume":"13","author":"Varona","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"11","key":"10.1016\/j.mam.2025.101412_bib80","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"issue":"6532","key":"10.1016\/j.mam.2025.101412_bib81","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1126\/science.abf4058","article-title":"Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A","volume":"371","author":"White","year":"2021","journal-title":"Science"},{"issue":"6532","key":"10.1016\/j.mam.2025.101412_bib82","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1126\/science.abf4058","article-title":"Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A","volume":"371","author":"White","year":"2021","journal-title":"Science"},{"issue":"20","key":"10.1016\/j.mam.2025.101412_bib83","doi-asserted-by":"crossref","first-page":"8625","DOI":"10.1021\/ja301735a","article-title":"Bacterial biosynthesis and maturation of the didemnin anti-cancer agents","volume":"134","author":"Xu","year":"2012","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.mam.2025.101412_bib84","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/00033197231153204","article-title":"Vascular \"long COVID\": a new vessel disease?","volume":"75","author":"Zanini","year":"2024","journal-title":"Angiology"},{"issue":"11","key":"10.1016\/j.mam.2025.101412_bib85","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1080\/1744666X.2022.2120472","article-title":"A systematic review and meta-analysis of the association between the neutrophil, lymphocyte, and platelet count, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio and COVID-19 progression and mortality","volume":"18","author":"Zinellu","year":"2022","journal-title":"Expet Rev. Clin. Immunol."}],"container-title":["Molecular Aspects of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299725000767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299725000767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T06:25:19Z","timestamp":1773815119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0098299725000767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":80,"alternative-id":["S0098299725000767"],"URL":"https:\/\/doi.org\/10.1016\/j.mam.2025.101412","relation":{},"ISSN":["0098-2997"],"issn-type":[{"value":"0098-2997","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological reprogramming of plitidepsin as a SARS-CoV-2 inhibitor","name":"articletitle","label":"Article Title"},{"value":"Molecular Aspects of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mam.2025.101412","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101412"}}